News > When and which Covid-19 vaccines are likely to be available in Asia
When and which Covid-19 vaccines are likely to be available in Asia
E-News | 01/12/2020 04:33 PM | Click to read full article
Moderna Inc applied for US and European emergency authorisation of its Covid-19 vaccine based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.
The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on November 23 the positive late-state trial result of the candidate will allow it to, before securing the OK for a full rollout by February or March.